NEXUS AG (NXU.DE) Stock Fundamental Analysis
FRA:NXU - Deutsche Boerse Ag - DE0005220909 - Common Stock - Currency: EUR
We assign a fundamental rating of 6 out of 10 to NXU. NXU was compared to 10 industry peers in the Health Care Technology industry. NXU gets an excellent profitability rating and is at the same time showing great financial health properties. NXU is valued quite expensively, but it does show have an excellent growth rating. This makes NXU very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
NXU had positive earnings in the past year.
NXU had a positive operating cash flow in the past year.
NXU had positive earnings in each of the past 5 years.
NXU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 6.82%, NXU perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
NXU has a Return On Equity (11.31%) which is in line with its industry peers.
NXU has a Return On Invested Capital of 8.78%. This is in the better half of the industry: NXU outperforms 70.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NXU is in line with the industry average of 8.54%.
The 3 year average ROIC (7.85%) for NXU is below the current ROIC(8.78%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.82% | ||
| ROE | 11.31% | ||
| ROIC | 8.78% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
1.3 Margins
With a decent Profit Margin value of 12.10%, NXU is doing good in the industry, outperforming 80.00% of the companies in the same industry.
NXU's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 15.58%, NXU belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
In the last couple of years the Operating Margin of NXU has grown nicely.
NXU has a better Gross Margin (85.51%) than 80.00% of its industry peers.
NXU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.58% | ||
| PM (TTM) | 12.1% | ||
| GM | 85.51% |
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NXU is creating some value.
Compared to 1 year ago, NXU has about the same amount of shares outstanding.
The number of shares outstanding for NXU has been increased compared to 5 years ago.
NXU has a better debt/assets ratio than last year.
2.2 Solvency
NXU has an Altman-Z score of 5.49. This indicates that NXU is financially healthy and has little risk of bankruptcy at the moment.
NXU's Altman-Z score of 5.49 is amongst the best of the industry. NXU outperforms 100.00% of its industry peers.
NXU has a debt to FCF ratio of 0.41. This is a very positive value and a sign of high solvency as it would only need 0.41 years to pay back of all of its debts.
NXU's Debt to FCF ratio of 0.41 is amongst the best of the industry. NXU outperforms 90.00% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that NXU is not too dependend on debt financing.
NXU has a better Debt to Equity ratio (0.05) than 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.41 | ||
| Altman-Z | 5.49 |
ROIC/WACC1.23
WACC7.15%
2.3 Liquidity
A Current Ratio of 1.93 indicates that NXU should not have too much problems paying its short term obligations.
NXU's Current ratio of 1.93 is fine compared to the rest of the industry. NXU outperforms 70.00% of its industry peers.
A Quick Ratio of 1.89 indicates that NXU should not have too much problems paying its short term obligations.
NXU has a Quick ratio of 1.89. This is in the better half of the industry: NXU outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.89 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 30.35% over the past year.
Measured over the past years, NXU shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.97% on average per year.
Looking at the last year, NXU shows a small growth in Revenue. The Revenue has grown by 7.65% in the last year.
NXU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.11% yearly.
EPS 1Y (TTM)30.35%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%25.55%
Revenue 1Y (TTM)7.65%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%11.17%
3.2 Future
NXU is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.50% yearly.
NXU is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.47% yearly.
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 37.61, the valuation of NXU can be described as expensive.
NXU's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of NXU to the average of the S&P500 Index (27.30), we can say NXU is valued slightly more expensively.
The Price/Forward Earnings ratio is 32.01, which means the current valuation is very expensive for NXU.
NXU's Price/Forward Earnings ratio is in line with the industry average.
NXU is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.61 | ||
| Fwd PE | 32.01 |
4.2 Price Multiples
NXU's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NXU is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.51 | ||
| EV/EBITDA | 15.93 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
NXU has a very decent profitability rating, which may justify a higher PE ratio.
NXU's earnings are expected to grow with 15.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.58
PEG (5Y)1.79
EPS Next 2Y14.95%
EPS Next 3Y15.5%
5. Dividend
5.1 Amount
NXU has a yearly dividend return of 0.32%, which is pretty low.
Compared to an average industry Dividend Yield of 4.20, NXU has a dividend in line with its industry peers.
With a Dividend Yield of 0.32, NXU pays less dividend than the S&P500 average, which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
5.2 History
The dividend of NXU has a limited annual growth rate of 2.17%.
Dividend Growth(5Y)2.17%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
11.69% of the earnings are spent on dividend by NXU. This is a low number and sustainable payout ratio.
The dividend of NXU is growing, but earnings are growing more, so the dividend growth is sustainable.
DP11.69%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
FRA:NXU (7/8/2025, 7:00:00 PM)
70.7
-0.7 (-0.98%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners55.8%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.22B
Analysts45.71
Price Target70.76 (0.08%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
Yearly Dividend0.22
Dividend Growth(5Y)2.17%
DP11.69%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.61 | ||
| Fwd PE | 32.01 | ||
| P/S | 4.55 | ||
| P/FCF | 24.51 | ||
| P/OCF | 20.28 | ||
| P/B | 4.25 | ||
| P/tB | 15.31 | ||
| EV/EBITDA | 15.93 |
EPS(TTM)1.88
EY2.66%
EPS(NY)2.21
Fwd EY3.12%
FCF(TTM)2.88
FCFY4.08%
OCF(TTM)3.49
OCFY4.93%
SpS15.55
BVpS16.63
TBVpS4.62
PEG (NY)2.58
PEG (5Y)1.79
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.82% | ||
| ROE | 11.31% | ||
| ROCE | 11.71% | ||
| ROIC | 8.78% | ||
| ROICexc | 15.25% | ||
| ROICexgc | N/A | ||
| OM | 15.58% | ||
| PM (TTM) | 12.1% | ||
| GM | 85.51% | ||
| FCFM | 18.55% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
ROICexc(3y)12.19%
ROICexc(5y)11.45%
ROICexgc(3y)147.03%
ROICexgc(5y)150.84%
ROCE(3y)10.47%
ROCE(5y)10.94%
ROICexcg growth 3Y-0.23%
ROICexcg growth 5Y4.33%
ROICexc growth 3Y3.77%
ROICexc growth 5Y2.6%
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.41 | ||
| Debt/EBITDA | 0.25 | ||
| Cap/Depr | 54.49% | ||
| Cap/Sales | 3.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 98.85% | ||
| Profit Quality | 153.36% | ||
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.89 | ||
| Altman-Z | 5.49 |
F-Score8
WACC7.15%
ROIC/WACC1.23
Cap/Depr(3y)46.55%
Cap/Depr(5y)41.01%
Cap/Sales(3y)3.52%
Cap/Sales(5y)3.36%
Profit Quality(3y)122.34%
Profit Quality(5y)137.83%
High Growth Momentum
Growth
EPS 1Y (TTM)30.35%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%25.55%
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.65%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%11.17%
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
EBIT growth 1Y27.31%
EBIT growth 3Y16.4%
EBIT growth 5Y15.93%
EBIT Next Year66.24%
EBIT Next 3Y29.63%
EBIT Next 5YN/A
FCF growth 1Y122.1%
FCF growth 3Y16.82%
FCF growth 5Y17.03%
OCF growth 1Y112.34%
OCF growth 3Y17.98%
OCF growth 5Y15.93%